The estimated Net Worth of Brian Mc Donough is at least $252 mil dollars as of 31 October 2022. Mr. Donough owns over 6,917 units of Quotient Ltd stock worth over $31,595 and over the last 10 years he sold QTNT stock worth over $0. In addition, he makes $219,998 as Independent Director at Quotient Ltd.
Sign up
Mr. McDonough QTNT stock SEC Form 4 insiders trading
Brian has made over 16 trades of the Quotient Ltd stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 6,917 units of QTNT stock worth $2,628 on 31 October 2022.
The largest trade he's ever made was exercising 10,493 units of Quotient Ltd stock on 10 July 2018 worth over $60,859. On average, Brian trades about 3,251 units every 64 days since 2014. As of 31 October 2022 he still owns at least 83,144 units of Quotient Ltd stock.
You can see the complete history of Mr. Donough stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Brian McDonough biography
Brian McDonough serves as Independent Director of the Company. Mr. McDonough is presently a Principal of Dx Consulting, a consultancy specializing in transfusion diagnostics. From 2003 through 2009, Mr. McDonough was Vice President, Worldwide Marketing, Donor Screening at Ortho-Clinical Diagnostics. From 2000 through 2003, he was President of the North American Blood Products Group of the Medical Division of Pall Corporation, a company specializing in medical filtration products. Prior to holding these senior executive positions, Mr. McDonough had an extensive career at the American Red Cross spanning over 30 years. From 1968 through 1982 Mr. McDonough worked in American Red Cross BioMedical Services as Executive Head of the St. Louis Regional Blood Services Unit. In 1982, he became the Executive Director of the Irwin Memorial Blood Bank of San Francisco, where he also served on several public health committees addressing the spread of AIDS. In 1987, Mr. McDonough returned to the American Red Cross as Regional Vice President of BioMedical Services and in 1994 served under Elizabeth Dole as Chief Operating Officer, Blood Services of the American Red Cross BioMedical Services, with overall responsibility for national blood and plasma programs. Mr. McDonough received a B.A. in liberal arts from Wichita State University and an M.H.A. from Central Michigan University.
What is the salary of Brian McDonough?
As the Independent Director of Quotient Ltd, the total compensation of Brian McDonough at Quotient Ltd is $219,998. There are 6 executives at Quotient Ltd getting paid more, with Franz Walt having the highest compensation of $2,290,340.
How old is Brian McDonough?
Brian McDonough is 73, he's been the Independent Director of Quotient Ltd since 2012. There are 1 older and 13 younger executives at Quotient Ltd. The oldest executive at Quotient Ltd is John Wilkerson, 77, who is the Independent Director.
What's Brian McDonough's mailing address?
Brian's mailing address filed with the SEC is 28 ESPLANADE, , ST HELIER, Y9, JE2 3QA.
Insiders trading at Quotient Ltd
Over the last 11 years, insiders at Quotient Ltd have traded over $5,237,327 worth of Quotient Ltd stock and bought 21,364,813 units worth $72,052,006 . The most active insiders traders include Advisors Llcperceptive Life..., Zubeen Shroff, eL John Wilkerson. On average, Quotient Ltd executives and independent directors trade stock every 15 days with the average trade being worth of $57,203. The most recent stock trade was executed by Catherine Larue on 31 January 2023, trading 438 units of QTNT stock currently worth $166.
What does Quotient Ltd's logo look like?
Complete history of Mr. Donough stock trades at Quotient Ltd
Quotient Ltd executives and stock owners
Quotient Ltd executives and other stock owners filed with the SEC include:
-
Franz Walt,
Chief Executive Officer, Director -
Edward Farrell,
Chief Operating Officer -
Jeremy Stackawitz,
Chief Commercial Officer -
Peter Buhler,
Chief Financial Officer -
Heino.N.F.M von Prondzynski,
Independent Chairman of the Board -
Frederick Hallsworth,
Independent Director -
Brian McDonough,
Independent Director -
Zubeen Shroff,
Independent Director -
John Wilkerson,
Independent Director -
Catherine Larue,
Independent Director -
Isabelle Buckle,
Independent Director -
Ernest Larnach,
Head - Financial Accounting & Treasury -
Esteban Uriarte,
Chief Manufacturing Operations Officer -
Mohammad El Khoury,
Chief Commercial Officer -
Christian Albrich,
Chief People Officer -
Dr. Christine Ginocchio,
Chief Scientific & Medical Officer -
Dr. Michael Hausmann,
Chief Technology Officer -
Vittoria Bonasso,
Head of Fin., Group Controller & Principal Accounting Officer -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
CEO & Director -
Ernest Larnach,
Head of Financial Accounting & Treasury -
Vittoria Bonasso,
See Remarks -
Roland Boyd,
See Remarks -
Thomas A Bologna,
Director -
Sarah A Oconnor,
Director -
Stephen Unger,
Chief Financial Officer -
Partners V Lp Galen Partner...,
-
Deidre Quotient Biodiagnost...,
-
D J Paul E Cowan,
See Remarks -
Sophie Bechu,
Director -
Advisors Llcperceptive Life...,
-
Christopher J Lindop,
EVP -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
Chief Executive Officer -
Khoury Mohammad El,
Chief Commercial Officer -
Thomas Aebischer,
Director